Annexon Biosciences
IPOUnited States · $234.0M raised
- Business Model
- B2B
- Total Funding
- $234.0M
- Last Round
- $125.0M Series DJun 2019
- Rounds
- 3
About
Clinical-stage biopharmaceutical company developing complement medicines targeting C1q for autoimmune, neurodegenerative, and ophthalmic diseases.
Summary
Annexon Biosciences is a Biotech company based in United States. It has raised $234.0M in total across 3 rounds, most recently a $125.0M Series D round in Jun 2019. Investors include Satter Investment and Correlation Ventures.
Tech & App Stack
6 technologies & apps tracked
Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jul 2020
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Specialty pharmaceutical company